MedTrace Logo

Prucalopride in Patients With Chronic Idiopathic Constipation

NCT00575614 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 87

Last updated 2008-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of chronic idiopathic constipation.

Hypothesis:

Prucalopride given at a dose of 1 mg o.d. for 4 weeks to female patients with chronic constipation shows a favourable effect on most of the efficacy parameters assessed in this trial. This dosage can be considered safe and generally well-tolerated.

Conditions

Interventions

DRUG

prucalopride

1 mg o.d.

DRUG

placebo

o.d.

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • Michael Kamm, MD · Northwick Park Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-04-30
Primary Completion
1999-03-31
Completion
1999-03-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575614 on ClinicalTrials.gov